Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States ...

Eli Lilly is investing an additional $27 billion ... D.C., brings the company's total U.S. manufacturing investment to more than $50 billion since 2020. The company's previous total domestic ...

WASHINGTON — Eli Lilly plans to spend $27 billion ... The company also touted its previous $23 billion investment in domestic manufacturing over the past four years, including the creation ...

Eli Lilly said Wednesday it will build three ... as part of what it called the largest manufacturing investment by a pharmaceutical firm in U.S. history. The announcement came at an event with ...

Indianapolis-based pharmaceutical giant Eli Lilly and Co. announced plans Wednesday to add four new manufacturing sites in a roughly $27 billion investment expected to create 3,000 jobs and nearly ...

Indianapolis-based Eli Lilly and Company announced nearly $2 billion in manufacturing investments in Ireland on Thursday. The pharmaceutical company said $1 billion of that investment will come in ...

Eli Lilly will spend $3 billion expanding a ... Kenosha County earlier this year from Nexus Pharma as part of a massive manufacturing investment drive that aims to shore up supplies of drugs ...

Eli Lilly's potential Houston expansion could bring thousands of jobs and billions of dollars in investment to the area. Here's where the plant might be built ...

Eli Lilly has doubled its investment in its new Concord manufacturing facility from $1 billion to $2 billion since construction began in 2022, the company confirmed. The pharmaceutical giant ...